GOSS announcements Gossamer Bio, Inc. announcements and dividends declared NASDAQ

Gossamer Bio, Inc. Complete list of announcements declared & dividend announcements by Gossamer Bio, Inc. GOSS

Gossamer Bio, Inc. GOSS listed on NASDAQ and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Gossamer Bio, Inc. GOSS

HC Wainwright & Co. Reiterates Gossamer Bio (GOSS) Buy Recommendation
Fintel reports that on May 11, 2023, HC Wainwright & Co. reiterated coverage of Gossamer Bio (NASDAQ:GOSS) with a Buy recommendation.
Announcement as on 11 May 2023

Gossamer Bio's stock falls 64% on findings for Phase 2 study for hypertension drug
Shares of Gossamer Bio Inc. plunged 64.5% in premarket trading on Tuesday after Wall Street analysts questioned the performance of the company's experimental hypertension drug in a Phase 2 clinical trial. Though Gossamer said the drug, seralutinib, met th
Announcement as on 06 December 2022

Why Gossamer Bio Stock Falling In Pre-market?
(RTTNews) - Gossamer Bio, Inc. (GOSS) reported topline results from its phase 2 SHIFT-UC clinical trial studying GB004 in patients with mild-to-moderate active ulcerative colitis. The company said neither statistically significant nor clinically meaningful
Announcement as on 25 April 2022

Gossamer Bio Appoints CFO Bryan Giraudo To Addl. Role Of COO - Quick Facts
(RTTNews) - Biopharmaceutical company Gossamer Bio, Inc. (GOSS) announced Tuesday that Bryan Giraudo has been appointed Chief Operating Officer, in addition to his continued role as Chief Financial Officer. Giraudo joined Gossamer in May 2018 as its Chief
Announcement as on 21 September 2021

Announcements by Gossamer Bio, Inc. first page |

GOSS Gossamer Bio, Inc. current price & indicator signals

Moving Averages for Gossamer Bio, Inc.

  • 5Day Average: 0.7
  • 12Day Average: 0.78
  • 20Day Average: 0.82
  • 50Day Average: 0.91
  • 100Day Average: 0.93
  • 150Day Average: 0.86
  • 200Day Average: 0.94

GOSS Indicators & signals

Indicator MACD (12,26,9)

0.75, 0.83, -0.06
Indicator MACD is in negative zone

Indicator ADX (14)

16.67, 70, 50
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 60
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of GOSS Gossamer Bio, Inc. are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
22 Fri Nov 2024 0.70 0.67 to 0.71 6.06% 1.53 times
21 Thu Nov 2024 0.66 0.66 to 0.72 -5.71% 0.98 times
20 Wed Nov 2024 0.70 0.68 to 0.72 -1.41% 0.86 times
19 Tue Nov 2024 0.71 0.68 to 0.75 -1.39% 0.97 times
18 Mon Nov 2024 0.72 0.72 to 0.75 -2.7% 0.51 times
15 Fri Nov 2024 0.74 0.74 to 0.78 -3.9% 0.53 times
14 Thu Nov 2024 0.77 0.76 to 0.83 -6.1% 1.9 times
13 Wed Nov 2024 0.82 0.80 to 0.88 -3.53% 1.64 times
12 Tue Nov 2024 0.85 0.82 to 0.88 -1.16% 1.08 times
11 Mon Nov 2024 0.86 0.85 to 0.89 -2.27% 0.7 times
08 Fri Nov 2024 0.88 0.85 to 0.90 -1.12% 0.84 times
07 Thu Nov 2024 0.89 0.88 to 0.92 0% 0.44 times

Videos related to: GOSS announcements Gossamer Bio, Inc. announcements and dividends declared NASDAQ

Videos related to: GOSS announcements Gossamer Bio, Inc. announcements and dividends declared NASDAQ

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

GOSS announcements Gossamer Bio, Inc. announcements and dividends declared NASDAQ

 

Back to top